Glycogen storage disease<unk>  3 is diagnosed by identification of proband by molecular genetic testing. Molecular genetic testing shows biallelic pathogenic variants in AGL for patients with GSD<unk>  3.
Glycogen storage disease type III diagnostic study of choice
Glycogen storage disease type II diagnostic study of choice
Glycogen storage disease type I diagnostic study of choice
Glycogen storage disease type II other diagnostic studies
Glycogen storage disease type III other diagnostic studies
Glycogen storage disease type I other diagnostic studies
Glycogen storage disease type I other imaging findings
Glycogen storage disease type II other imaging findings